SCHEMBL22818023

SCHEMBL22818023

c1ccc(-c2ccc(-c3cccc4oc5c6ccccc6c(N(c6ccc(-c7ccccc7)cc6)c6cccc(-c7ccccc7)c6)cc5c34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.36
▸ PLA2G2A P14555 3/20 0.32
▸ PLA2G4A P47712 3/20 0.32
▸ PIM1 P11309 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2B P67870 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ CDC14B O60729 1/20 0.31
▸ CDC14A Q9UNH5 1/20 0.31
▸ PLA2G10 O15496 1/20 0.30
▸ GGPS1 O95749 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817869 1.00 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22818322 1.00 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22817821 1.00 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22817968 1.00 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22817947 1.00 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22818541 0.99 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22818054 0.99 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22818063 0.99 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22817799 0.98 ALOX5 (0.35) ALOX5PLA2G2APLA2G4APIM1CSNK2A2
SCHEMBL22818455 0.97 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APIM1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback